Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
JCI Insight|September 22, 2022
Lower SARS-CoV-2-specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19Daniel J Schuster, Shelly Karuna, Caroline Brackett, et al.
The Journal of Clinical Investigation|June 24, 2021
Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challengeRena D Astronomo, Maria P Lemos, Sandeep R Narpala, et al.
The Lancet. Infectious Diseases|April 22, 2021
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging studyPaul A Goepfert, Bo Fu, Anne-Laure Chabanon, et al.
The Journal of Clinical Investigation|October 1, 2019
DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trialNadine G Rouphael, Cecilia Morgan, Shuying S Li, et al.
Cell Reports|October 19, 2022
SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinationsElizabeth M Anderson, Shuk Hang Li, Moses Awofolaju, et al.
Journal of Virology|August 23, 2019
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine TrialShuying S Li, Peter B Gilbert, Lindsay N Carpp, et al.
Annals of Internal Medicine|April 28, 2025
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302)Sharon A Riddler, Zoe Moodie, Jesse Clark, et al.
Clinical and Vaccine Immunology : CVI|September 22, 2017
DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8<sup>+</sup> T-Cell Responses by Interleukin-12 Plasmid DNAShuying S Li, Nidhi K Kochar, Marnie Elizaga, et al.
The Journal of Infectious Diseases|July 11, 2013
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for deliverySpyros A Kalams, Scott D Parker, Marnie Elizaga, et al.
AIDS and Behavior|June 10, 2022
Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305)Kenneth H Mayer, Krista Yuhas, K Rivet Amico, et al.
Pageof 16